Clincosm LogoSign in Get a demo

non alcoholic steatohepatitis

Showing 1 - 25 of 33
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Alcoholic Steatohepatitis Trial in Tanta (Diosmin, Placebo)

Recruiting
  • Non Alcoholic Steatohepatitis
  • Tanta, Egypt
    Tanta University
Jul 5, 2023

Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Fecal Microbiota Transplantation Trial in Amsterdam

Recruiting
  • Non Alcoholic Steatohepatitis
  • +8 more
  • LFMT-capsules
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC
Apr 6, 2023

Non Alcoholic Steatohepatitis Trial in Tanta (Pioglitazone 30mg, Empagliflozin 10 MG)

Not yet recruiting
  • Non Alcoholic Steatohepatitis
  • Pioglitazone 30mg
  • Empagliflozin 10 MG
  • Tanta, Gharbiya, Egypt
    Tanta University
Nov 2, 2022

Non Alcoholic Steatohepatitis, Hyperuricemia Trial in Tanta (Febuxostat 80 MG Oral Tablet, vit E)

Recruiting
  • Non Alcoholic Steatohepatitis
  • Hyperuricemia
  • Febuxostat 80 MG Oral Tablet
  • vit E
  • Tanta, Egypt
    Department of Tropical Medicine and Infectious Diseases, Faculty
Oct 8, 2022

Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis, Hepatic Steatosis Trial (Fructo-oligosaccharide supplement,

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +2 more
  • Fructo-oligosaccharide supplement
  • Maltodextrin
  • (no location specified)
Jul 27, 2022

Non Alcoholic Steatohepatitis Trial in Roma, Rome (RYGB, SG, Intensive Lifestyle Modification)

Completed
  • Non Alcoholic Steatohepatitis
  • RYGB
  • +2 more
  • Roma, Italy
  • +2 more
Jul 20, 2022

Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)

Not yet recruiting
  • Cancer Risk
  • +30 more
  • Samples
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 14, 2022

Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis Trial in Giza (Genomics (DNA Extraction), Epi-genomics,

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Non Alcoholic Steatohepatitis
  • Genomics (DNA Extraction)
  • +4 more
  • Giza, Al Jizah, Egypt
    National Research Centre
Jun 1, 2022

Patient Demographics, Comorbidities, and Medications on Severity

Completed
  • Non-Alcoholic Fatty Liver Disease
  • Non Alcoholic Steatohepatitis
  • NAFLD/NASH
  • Dallas, Texas
    Methodist Dallas Medical Center
Apr 27, 2022

Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis Trial in Majadahonda (Fecal Microbiota Transplantation)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Non Alcoholic Steatohepatitis
  • Fecal Microbiota Transplantation
  • Majadahonda, Madrid, Spain
    Puerta de Hierro University Hospital
Apr 13, 2022

Nonalcoholic Fatty Liver Disease (NAFLD) in Adults

Completed
  • Non-Alcoholic Fatty Liver Disease
  • Non Alcoholic Steatohepatitis
  • non-applicable
  • Fort Sam Houston, Texas
    San Antonio Military Medical Center
Mar 21, 2022

Non Alcoholic Steatohepatitis Trial in San Diego, New York (Elafibranor 80mg, Elafibranor 120mg)

Terminated
Has Results
  • Non Alcoholic Steatohepatitis
  • Elafibranor 80mg
  • Elafibranor 120mg
  • San Diego, California
  • +1 more
Sep 29, 2021

Non Alcoholic Steatohepatitis Trial in Redwood City, Stanford (Idebenone, Placebo)

Recruiting
  • Non Alcoholic Steatohepatitis
  • Redwood City, California
  • +1 more
Jul 16, 2021

Coffee Consumption and NASH in the French Population.

Completed
  • Non Alcoholic Steatohepatitis
    • Béziers, France
    • +15 more
    Jan 27, 2021

    Non Alcoholic Steatohepatitis Trial in United States (Saroglitazar Magnesium 2mg, Saroglitazar Magnesium 4mg, Placebos)

    Completed
    • Non Alcoholic Steatohepatitis
    • Saroglitazar Magnesium 2mg
    • +2 more
    • Jackson, Mississippi
    • +5 more
    Dec 11, 2020

    The Role of Immune Semaphorins in NAFLD

    Unknown status
    • Non-Alcoholic Fatty Liver Disease
    • +4 more
    • Evaluation of the degree of fibrosis and steatosis
    • +3 more
    • Zagreb, Croatia
      University Hospital for Infectious Diseases Zagreb
    Sep 29, 2020

    Expanding Donor Pool for Live Donor Liver Transplantation:

    Completed
    • Non Alcoholic Steatohepatitis
    • No Intervention
    • New Delhi, Delhi, India
      Institute of Liver & Biliary Sciences
    Sep 26, 2020

    Non Alcoholic Steatohepatitis Trial in Tanta (Placebo, Montelukast)

    Completed
    • Non Alcoholic Steatohepatitis
    • Tanta, El-Gharbia, Egypt
      Dr. Tarek Mohamed Mostafa
    Aug 30, 2020

    Non Alcoholic Steatohepatitis Trial in San Diego (Ezetimibe)

    Completed
    Has Results
    • Non Alcoholic Steatohepatitis
    • San Diego, California
      University of California, San Diego
    Jul 1, 2020

    Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese

    Completed
    • Morbid Obesity
    • Non Alcoholic Steatohepatitis
      • Colombes, France
        Hôpital Louis Mourier
      Dec 18, 2019

      Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis, NASH - Nonalcoholic Steatohepatitis Trial (Moderate intensity

      Withdrawn
      • Non-Alcoholic Fatty Liver Disease
      • +2 more
      • Moderate intensity aerobic exercise
      • (no location specified)
      Nov 26, 2019

      Non Alcoholic Steatohepatitis Trial in Tehran (Dietary Supplement: hesperidin and flaxseed, Dietary Supplement: hesperidin,

      Unknown status
      • Non Alcoholic Steatohepatitis
      • Dietary Supplement: hesperidin and flaxseed
      • +3 more
      • Tehran, Iran (the Islamic Republic Of), Iran, Islamic Republic of
        National Nutrition and Food Technology Research Institute
      Nov 6, 2018

      Non Alcoholic Steatohepatitis Trial in New Delhi (Fecal Microbiota Transplant, Standard Medical Treatment)

      Unknown status
      • Non Alcoholic Steatohepatitis
      • Fecal Microbiota Transplant
      • Standard Medical Treatment
      • New Delhi, Delhi, India
        Institute of Liver & Biliary Sciences
      Feb 13, 2018

      Non Alcoholic Steatohepatitis Trial in Tehran (Hesperidin, control)

      Unknown status
      • Non Alcoholic Steatohepatitis
      • Hesperidin
      • control
      • Tehran, Iran, Islamic Republic of
        National Nutrition and Food Technology Research Institute
      Dec 13, 2017

      Non Alcoholic Steatohepatitis Trial in Tehran (hesperidin and flaxseed, control)

      Unknown status
      • Non Alcoholic Steatohepatitis
      • hesperidin and flaxseed
      • control
      • Tehran, Iran, Islamic Republic of
        National Nutrition and Food Technology Research Institute
      Dec 13, 2017